Literature DB >> 8634419

Expression of HOXC4, HOXC5, and HOXC6 in human lymphoid cell lines, leukemias, and benign and malignant lymphoid tissue.

J Bijl1, J W van Oostveen, M Kreike, E Rieger, L M van der Raaij-Helmer, J M Walboomers, G Corte, E Boncinelli, A J van den Brule, C J Meijer.   

Abstract

Besides their regulatory role in embryogenesis, homeobox (HOX) genes are expressed in a specific manner in hematopoietic cell lineages, implying a role in the molecular regulation of hematopoiesis. Some HOX C cluster genes are found to be expressed in lymphoid cells of mice and humans. Their function and expression in normal hematopoiesis are still largely unknown. We have studied the mRNA expression of HOXC4, HOXC5, and HOXC6 in several stages of lymphocyte maturation by reverse transcriptase-polymerase chain reaction (RT-PCR) and RNA in situ hybridization (RISH). We examined CD34+/CD38low and CD34+/CD38high cells obtained from normal donor bone marrow (BM), a panel of 19 lymphoid cell lines, several types of leukemias and non-Hodgkin's lymphomas (NHL), and lymphocytes isolated from tonsillar tissue and peripheral blood (PB). HOXC4 and HOXC6 were found to be expressed during maturation in B- and T-lymphoid cells. The expression of each gene was found to be initiated at different cell maturation stages. HOXC4 transcripts were present in CD34+/CD38low cells, which are thought to comprise stem cells and noncommitted progenitor cells, and in subsequent stages to terminally maturated lymphoid cells. HOXC6 expression is initiated in equivalents of prothymocyte and pre-pre-B cell stage and remains present in mature cells. However, HOXC5 is only expressed in neoplastic cell lines and in neoplastic cells of NHL, but not in CD34+ BM cells, nor in resting or activated lymphoid cells isolated from tonsil, PB, or in leukemia cells. In cell lines, weak expression of HOXC5 is initiated in equivalents of pre-B cell and common thymocyte stage and is continuously expressed in mature cell lines. Semi-quantitative RT-PCR showed that expression levels of HOXC5 were much lower than those of HOXC4 and HOXC6; furthermore an increase of expression of HOXC4, HOXC5, and HOXC6 during lymphoid cell differentiation was demonstrated. Thus, mainly mature lymphoid cell lines and neoplastic cells of NHL do express HOXC5, in contrast to the lack of expression in normal lymphoid cells and leukemias. These findings suggest involvement of HOXC5 in lymphomagenesis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8634419

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  19 in total

1.  HOXC4, HOXC5, and HOXC6 expression in primary cutaneous lymphoid lesions. High expression of HOXC5 in anaplastic large-cell lymphomas.

Authors:  J J Bijl; E Rieger; J W van Oostveen; J M Walboomers; M Kreike; R Willemze; C J Meijer
Journal:  Am J Pathol       Date:  1997-10       Impact factor: 4.307

2.  Bisphenol-A induces expression of HOXC6, an estrogen-regulated homeobox-containing gene associated with breast cancer.

Authors:  Imran Hussain; Arunoday Bhan; Khairul I Ansari; Paromita Deb; Samara A M Bobzean; Linda I Perrotti; Subhrangsu S Mandal
Journal:  Biochim Biophys Acta       Date:  2015-02-25

3.  Activity of the EBNA1 promoter associated with lytic replication (Fp) in Epstein-Barr virus associated disorders.

Authors:  A A Brink; C J Meijer; J M Nicholls; J M Middeldorp; A J van den Brule
Journal:  Mol Pathol       Date:  2001-04

4.  HOXC6 is deregulated in human head and neck squamous cell carcinoma and modulates Bcl-2 expression.

Authors:  Sung-Min Moon; Soo-A Kim; Jung-Hoon Yoon; Sang-Gun Ahn
Journal:  J Biol Chem       Date:  2012-08-15       Impact factor: 5.157

Review 5.  The Hox genes and their roles in oncogenesis.

Authors:  Nilay Shah; Saraswati Sukumar
Journal:  Nat Rev Cancer       Date:  2010-04-01       Impact factor: 60.716

6.  Interplay between promoter methylation and chromosomal loss in gene silencing at 3p11-p14 in cervical cancer.

Authors:  Malin Lando; Christina S Fjeldbo; Saskia M Wilting; Barbara C Snoek; Eva-Katrine Aarnes; Malin F Forsberg; Gunnar B Kristensen; Renske Dm Steenbergen; Heidi Lyng
Journal:  Epigenetics       Date:  2015       Impact factor: 4.528

7.  Embryonic stem cell-derived hematopoietic stem cells.

Authors:  Yuan Wang; Frank Yates; Olaia Naveiras; Patricia Ernst; George Q Daley
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-15       Impact factor: 11.205

8.  Ectopic expression of HOXC6 blocks myeloid differentiation and predisposes to malignant transformation.

Authors:  Melanie Wurm; John Kowalski; Dirk Heckl; Xiao-Bing Zhang; Veronica Nelson; Brian C Beard; Hans-Peter Kiem
Journal:  Exp Hematol       Date:  2013-10-26       Impact factor: 3.084

9.  Nucleic acid sequence-based amplification, a new method for analysis of spliced and unspliced Epstein-Barr virus latent transcripts, and its comparison with reverse transcriptase PCR.

Authors:  A A Brink; M B Vervoort; J M Middeldorp; C J Meijer; A J van den Brule
Journal:  J Clin Microbiol       Date:  1998-11       Impact factor: 5.948

10.  HoxC4 binds to the promoter of the cytidine deaminase AID gene to induce AID expression, class-switch DNA recombination and somatic hypermutation.

Authors:  Seok-Rae Park; Hong Zan; Zsuzsanna Pal; Jinsong Zhang; Ahmed Al-Qahtani; Egest J Pone; Zhenming Xu; Thach Mai; Paolo Casali
Journal:  Nat Immunol       Date:  2009-04-12       Impact factor: 25.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.